Back to today’s briefing

Story perspectives

Genetic Variants May Shield Childhood Cancer Survivors' Hearts

6/25/2025

30 4

Summary

Story summary

Childhood cancer survivors are at an increased risk of developing late-onset cardiomyopathy (CCM), according to groundbreaking research from St. Jude Children’s Research Hospital. However, genetic variants TTN (rs3829746-C) and BAG3 (rs2234962-C) could potentially lower this risk. This study underscores the urgent need for enhanced genetic screening to better predict and manage long-term heart health in these brave survivors.

1 of 1

Story summary

Childhood cancer survivors are at an increased risk of developing late-onset cardiomyopathy (CCM), according to groundbreaking research from St. Jude Children’s Research Hospital. However, genetic variants TTN (rs3829746-C) and BAG3 (rs2234962-C) could potentially lower this risk. This study underscores the urgent need for enhanced genetic screening to better predict and manage long-term heart health in these brave survivors.